---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-124568"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2024-12-02T23:59:59+00:00"
generated_at: "2026-05-29T11:13:11.743875+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ReShape Lifesciences receives Nasdaq delisting notice for stockholders' equity below $2.5M

## Summary
- As of Sept 30, 2024, stockholders' equity was $1,487,000, below Nasdaq's $2.5M minimum.
- Company has 45 days to submit a compliance plan; if accepted, Nasdaq may grant up to 180-day extension.
- Intends to monitor performance and consider available options to regain compliance.

## SEC filing metadata
- accession: 0001104659-24-124568
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2024-12-02T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465924124568/0001104659-24-124568-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465924124568/tm2419158d7_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-124568
- JSON: https://secwatch.observer/filing/0001104659-24-124568.json
- Plain text: https://secwatch.observer/filing/0001104659-24-124568.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.